Proteomics-based analysis of xenografted breast cancers revealed that highly aggressive and metastatic cancer cell lines produced ECM components such as fibronectin, fibrinogen, laminins, periostin, collagens I, III, IV, V, and VI, transglutaminase 2, and hyaluronan. The gene discussed is FN1; the disease is breast cancer.